Prosecution Insights
Last updated: April 19, 2026

Iregene Therapeutics Ltd.

3 pending office actions

Portfolio Summary

3
Total Pending OAs
1
Final Rejections
2
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18269551 MARKER GENE FOR IDENTIFYING AND CLASSIFYING DPC CELL, SCREENING METHOD THEREFOR AND USE THEREOF HANEY, AMANDA MARIE 1682 Final Rejection Jun 24, 2023
18031877 CHEMICAL CULTURE SYSTEM AND USE THEREOF ROGERS, ERIC JASON 1638 Non-Final OA Apr 14, 2023
17999288 SERUM-FREE INDUCTION METHOD FOR SENSORY NEURON CELL ROGERS, ERIC JASON 1638 Non-Final OA Jan 18, 2023

Managing Iregene Therapeutics Ltd.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month